Loading…
BRS Biotech provides pilot-scale bioreactors designed to bridge the gap between laboratory research and industrial biomanufacturing. The company's platform focuses on the rigorous testing, validation, and compliance needed to achieve process scalability, economic feasibility, and regulatory readiness.
AI named BRS Biotech from February 2026 to March 2026.